This content is restricted.
Brief
On February 14, 2025, the National Agency for Food, Environmental and Occupational Health Safety (ANSES) issued an update regarding ANSES offers to classify resorcinol as an endocrine disruptor in the European CLP regulation. This proposal is based on evidence that resorcinol impacts thyroid function, with harmful effects, and aligns with the recent addition of this classification category in the CLP regulation.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested